HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Palliative uses of methylphenidate in patients with cancer: a review.

AbstractPURPOSE:
Cancer is, unfortunately, often a terminal disease. The goal of therapy for many patients with cancer is palliation of symptoms common at the end of life, including pain, depression, and cognitive dysfunction. Methylphenidate is a psychostimulant most commonly used in the treatment of attention deficit hyperactivity disorder. In this report, we review the use of methylphenidate in the palliative care of patients with cancer.
METHODS:
This review was written on the basis of a computerized literature search of Medline. We considered all English language publications from 1966 to present using the following key words: methylphenidate, palliative care, and cancer. Forty-nine articles were identified as being relevant for this review.
RESULTS:
On the basis of this review, we came to the conclusion that methylphenidate is used to ameliorate opioid-induced somnolence, to augment the analgesic effects of opioids, to treat depression, and to improve cognitive function in patients with cancer.
CONCLUSION:
The medical literature supports the palliative use of methylphenidate in the care of patients with cancer. Further placebo-controlled trials are needed to elucidate the precise role that methylphenidate will have in providing symptom relief to dying patients.
AuthorsMark Rozans, Albert Dreisbach, Juan J L Lertora, Marc J Kahn
JournalJournal of clinical oncology : official journal of the American Society of Clinical Oncology (J Clin Oncol) Vol. 20 Issue 1 Pg. 335-9 (Jan 01 2002) ISSN: 0732-183X [Print] United States
PMID11773187 (Publication Type: Journal Article, Review)
Chemical References
  • Analgesics, Opioid
  • Central Nervous System Stimulants
  • Methylphenidate
Topics
  • Analgesics, Opioid (adverse effects)
  • Central Nervous System Stimulants (therapeutic use)
  • Cognition Disorders (drug therapy, etiology)
  • Depression (drug therapy, etiology)
  • Disorders of Excessive Somnolence (chemically induced, drug therapy)
  • Humans
  • Methylphenidate (therapeutic use)
  • Neoplasms (complications, drug therapy)
  • Palliative Care (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: